Adaptive Biotechnologies (ADPT) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

For the quarter ended September 2024, Adaptive Biotechnologies (ADPT) reported revenue of $46.44 million, up 22.5% over the same period last year. EPS came in at -$0.22, compared to -$0.35 in the year-ago quarter.The reported revenue represents a surprise of +14.41% over the Zacks Consensus Estimate of $40.59 million. With the consensus EPS estimate being -$0.30, the EPS surprise was +26.67%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they comp ...